Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Clin Chem Lab Med ; 62(6): 1177-1197, 2024 May 27.
Artículo en Inglés | MEDLINE | ID: mdl-38332693

RESUMEN

OBJECTIVES: To identify molecular pathways and prognostic- and diagnostic plasma-protein biomarkers for diabetic retinopathy at various stages. METHODS: This exploratory, cross-sectional proteomics study involved plasma from 68 adults, including 15 healthy controls and 53 diabetes patients for various stages of diabetic retinopathy: non-diabetic retinopathy, non-proliferative diabetic retinopathy, proliferative diabetic retinopathy and diabetic macular edema. Plasma was incubated with peptide library beads and eluted proteins were tryptic digested, analyzed by liquid chromatography-tandem mass-spectrometry followed by bioinformatics. RESULTS: In the 68 samples, 248 of the 731 identified plasma-proteins were present in all samples. Analysis of variance showed differential expression of 58 proteins across the five disease subgroups. Protein-Protein Interaction network (STRING) showed enrichment of various pathways during the diabetic stages. In addition, stage-specific driver proteins were detected for early and advanced diabetic retinopathy. Hierarchical clustering showed distinct protein profiles according to disease severity and disease type. CONCLUSIONS: Molecular pathways in the cholesterol metabolism, complement system, and coagulation cascade were enriched in patients at various stages of diabetic retinopathy. The peroxisome proliferator-activated receptor signaling pathway and systemic lupus erythematosus pathways were enriched in early diabetic retinopathy. Stage-specific proteins for early - and advanced diabetic retinopathy as determined herein could be 'key' players in driving disease development and potential 'target' proteins for future therapies. For type 1 and 2 diabetes mellitus, the proteomic profiles were especially distinct during the early disease stage. Validation studies should aim to clarify the role of the detected molecular pathways, potential biomarkers, and potential 'target' proteins for future therapies in diabetic retinopathy.


Asunto(s)
Biomarcadores , Proteínas Sanguíneas , Retinopatía Diabética , Proteómica , Humanos , Retinopatía Diabética/diagnóstico , Retinopatía Diabética/sangre , Retinopatía Diabética/metabolismo , Biomarcadores/sangre , Proteómica/métodos , Masculino , Femenino , Persona de Mediana Edad , Proteínas Sanguíneas/análisis , Proteínas Sanguíneas/metabolismo , Pronóstico , Adulto , Estudios Transversales , Espectrometría de Masas en Tándem , Anciano , Mapas de Interacción de Proteínas
2.
Ugeskr Laeger ; 185(3)2023 01 16.
Artículo en Danés | MEDLINE | ID: mdl-36760141

RESUMEN

Strabismus is a common condition affecting both children and adults. Strabismus patients may experience double vision, abnormal head position and loss of stereovision. The psychosocial negative impact of strabismus may be severe, affect self-esteem, social relationships, and job opportunities. Strabismus is a congenital condition or a result of an illness in later life and surgical treatment should be considered as reconstructive surgery and not downrated as just ¼a cosmetic procedure«. Strabismus surgery is safe, effective and addresses functional as well as psychosocial problems.


Asunto(s)
Procedimientos de Cirugía Plástica , Estrabismo , Adulto , Niño , Humanos , Estrabismo/cirugía , Estrabismo/etiología , Músculos Oculomotores/cirugía , Relaciones Interpersonales
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA